Clinical Trial Update: Study of Oral Upadacitinib to Assess Change in Disease Activity and Adverse Events in Adult Participants With Ulcerative Colitis or Crohn's Disease

View source ↗

Summary

This clinical trial update reports the completion of a study evaluating upadacitinib for disease activity and safety in adults with ulcerative colitis or Crohn'…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Ulcerative Colitis

Drugs mentioned

• Upadacitinib (upadacitinib)

Snippet

Sponsor: AbbVie | Conditions: Ulcerative Colitis, Crohn's Disease | Status: COMPLETED